ClassID:

95054

C07D311/38 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only 2,3-Dihydro derivatives, e.g. isoflavanones

Recent Application in this class:
#1
20180186762
2018-07-05

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#2
20170305876
2017-10-26

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#3
20170283389
2017-10-05

Synthesis of isoflavanes and intermediates thereof

#4
20150352074
2015-12-10

Substituted chroman derivatives, medicaments and use in therapy

#5
20150274692
2015-10-01

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#6
20150148409
2015-05-28

Daidzein analogs as treatment for cancer

#7
20140221468
2014-08-07

Compounds that Modulate Store Operated Calcium Channels

#8
20140170243
2014-06-19

Substituted chroman derivatives, medicaments and use in therapy

#9
20140161908
2014-06-12

Chroman derivatives, medicaments and use in therapy

#10
20140005149
2014-01-02

Substituted diphenyl derivatives

#11
20130296582
2013-11-07

Inhibition and treatment of prostate cancer metastasis

#12
20130184475
2013-07-18

Daidzein analogs as treatment for cancer

#13
20130116450
2013-05-09

Method for enantioselective hydrogenation of chromenes

#14
20120172424
2012-07-05

Chroman derivatives, medicaments and use in therapy

#15
20120114766
2012-05-10

Substituted chroman derivatives, medicaments and use in therapy

#16
20120094336
2012-04-19

Synthesis of equol

#17
20120046353
2012-02-23

CLEISTOCALYX OPERCULATUS-DERIVED COMPOUNDS HAVING INHIBITORY ACTIVITIES AGAINST AVIAN AND SWINE INFLUENZA VIRUSES OR NOVEL INFLUENZA VIRUS

#18
20120004427
2012-01-05

Method for enantioselective hydrogenation of chromenes

#19
20120004296
2012-01-05

Chroman derivatives, medicaments and use in therapy

#20
20110166142
2011-07-07

2-SUBSTITUTED ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USES

#21
20100273891
2010-10-28

ISOFLAVONE METABOLITES

#22
20100137425
2010-06-03

Inhibition and treatment of prostate cancer metastasis

#23
20100069653
2010-03-18

Method for enantioselective hydrogenation of chromenes

#24
20090317490
2009-12-24

Substituted chroman derivatives, medicaments and use in therapy

#25
20090233999
2009-09-17

COMPOSITIONS AND THERAPEUTIC METHODS INVOLVING ISOFLAVONES AND ANALOGUES THEREOF

#26
20090209655
2009-08-20

Isoflavone metabolites

#27
20090192152
2009-07-30

Novel Antigiardial Agents and Methods of Use Thereof

#28
20090062555
2009-03-05

Synthesis of Isoflavone

#29
20080274519
2008-11-06

FLAVONOID CONCENTRATES

#30
20080125481
2008-05-29

ISOFLAVONE METABOLITES

#31
20080014249
2008-01-17

Compositions and therapeutic methods involving isoflavones and analogues thereof

#32
20070099826
2007-05-03

Treatment of diseases associated with the egr-1 enhancer element

#33
20070027329
2007-02-01

Method for enantioselective hydrogenation of chromenes

#34
20060217564
2006-09-28

Production of isoflavone derivatives

#35
20060106220
2006-05-18

Compositions and therapeutic methods involving isoflavones and analogues thereof

#36
20060106091
2006-05-18

Antigiardial agents and use thereof

#37
20060074127
2006-04-06

Substituted chroman derivatives, medicaments and use in therapy

#38
20060074126
2006-04-06

Chroman derivatives, medicaments and use in therapy

#39
20050222248
2005-10-06

Isoflavone metabolites

#40
20050209313
2005-09-22

Flavonoid concentrates

#41
20050143588
2005-06-30

Production of isoflavone derivatives